investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting Chromatin Modifications in Leukemia with Trisomy 21
Andrew A Lane
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew A Lane
Dana-Farber Cancer Institute
Boston, United States
Related projects
Mary Ellen Conley
Genetic Etiology of Agammaglobulinemia with Absent B Cells
Leukaemia
Dean W Felsher
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death
Leukaemia
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
Ravi Bhatia
Microenvironmental Regulation of Leukemia Stem Cells
Leukaemia
Hematology and hematologic malignancies
Gerd P Pfeifer
5-hydroxymethylcytosine in Human Cancer
Leukaemia
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Hematology and hematologic malignancies
Guy S Salvesen
IAP Family Proteins and Cancer
Leukaemia
Pathology
Hematology and hematologic malignancies
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Leukaemia
Kenneth Lynn Wright
Natural Killer Cell Regulation by PRDM1 and IRF4/8
Leukaemia